WebDec 4, 2024 · Approximately 2 years ago, we launched the Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis (TARGET) trial (ClinicalTrials.gov Identifier: NCT02053909) to evaluate the potential benefits of ticagrelor 90 mg twice daily, compared with aspirin 81 mg twice daily, on 1- and 2-year graft patency after CABG. 15 Given the … WebApr 15, 2024 · Deepak Bhatt, MD: Guidance on Antiplatelet Therapy in Diabetics with CAD. Bhatt leads discussion on a new AHA statement regarding one of the most …
UpToDate
WebMar 1, 2024 · Antithrombotic therapy should be considered in all those with diabetes and established ASCVD or AF. Intensification of antithrombotic therapy is typically indicated during the acute phase of an … WebDec 18, 2024 · If triple therapy is needed, a short duration (e.g., no more than 30 days) is recommended. When combined with an anticoagulant, clopidogrel is the recommended antiplatelet agent for most patients. If aspirin is being used, it should be limited to <100 mg daily dosing. For patients taking ≥2 antithrombotic agents, starting or continuing a ... can someone legally record a conversation
Management of Stable Coronary Artery Disease in …
WebAntiplatelet drugs are sometimes used to prevent blood clots, heart attacks and strokes, but are primarily used to prevent the recurrence of blood clots after a heart attack or stroke. … WebThere is considerable inter-individual variation in the efficacy of established antiplatelet drugs, and high on-treatment platelet reactivity is associated with an increased risk of … WebAug 16, 2024 · Severe vitamin D deficiency in people with diabetes treated with dual antiplatelet therapy (DAPT) after an acute coronary syndrome (ACS) or percutaneous coronary intervention (PCI) is associated with high residual platelet reactivity in patients taking the adenosine-diphosphate (ADP) antagonists ticagrelor or prasugrel, according to … flare base dong